Correlation Between G1 Therapeutics and Beam Therapeutics
Can any of the company-specific risk be diversified away by investing in both G1 Therapeutics and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G1 Therapeutics and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G1 Therapeutics and Beam Therapeutics, you can compare the effects of market volatilities on G1 Therapeutics and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G1 Therapeutics with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of G1 Therapeutics and Beam Therapeutics.
Diversification Opportunities for G1 Therapeutics and Beam Therapeutics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between GTHX and Beam is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding G1 Therapeutics and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and G1 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G1 Therapeutics are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of G1 Therapeutics i.e., G1 Therapeutics and Beam Therapeutics go up and down completely randomly.
Pair Corralation between G1 Therapeutics and Beam Therapeutics
If you would invest 2,436 in Beam Therapeutics on September 5, 2024 and sell it today you would earn a total of 162.00 from holding Beam Therapeutics or generate 6.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
G1 Therapeutics vs. Beam Therapeutics
Performance |
Timeline |
G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Beam Therapeutics |
G1 Therapeutics and Beam Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with G1 Therapeutics and Beam Therapeutics
The main advantage of trading using opposite G1 Therapeutics and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G1 Therapeutics position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |